These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9628546)

  • 1. The selective estrogen receptor modulator, raloxifene: an overview of nonclinical pharmacology and reproductive and developmental testing.
    Buelke-Sam J; Bryant HU; Francis PC
    Reprod Toxicol; 1998; 12(3):217-21. PubMed ID: 9628546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The selective estrogen receptor modulator, raloxifene: a segment II/III delivery study in rats.
    Buelke-Sam J; Cohen IR; Wierda D; Griffey KI; Fisher LF; Francis PC
    Reprod Toxicol; 1998; 12(3):271-88. PubMed ID: 9628551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The selective estrogen receptor modulator, raloxifene: segment II studies in rats and rabbits.
    Byrd RA; Francis PC
    Reprod Toxicol; 1998; 12(3):261-70. PubMed ID: 9628550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The selective estrogen receptor modulator, raloxifene: reproductive assessments following preimplantation exposure in mated female rats.
    Clarke DO; Griffey KI; Buelke-Sam J; Francis PC
    Reprod Toxicol; 1998; 12(3):247-59. PubMed ID: 9628549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The selective estrogen receptor modulator, raloxifene: reproductive assessments following premating exposure in female rats.
    Hoyt JA; Fisher LF; Buelke-Sam JL; Francis PC
    Reprod Toxicol; 1998; 12(3):233-45. PubMed ID: 9628548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine and antiprostatic effects of raloxifene (LY156758) in the male rat.
    Neubauer BL; Best KL; Clemens JA; Gates CA; Goode RL; Jones CD; Laughlin ME; Shaar CJ; Toomey RE; Hoover DM
    Prostate; 1993; 23(3):245-62. PubMed ID: 8234067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The selective estrogen receptor modulator, raloxifene: reproductive assessments in adult male rats.
    Hoyt JA; Fisher LF; Swisher DK; Byrd RA; Francis PC
    Reprod Toxicol; 1998; 12(3):223-32. PubMed ID: 9628547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats.
    Black LJ; Sato M; Rowley ER; Magee DE; Bekele A; Williams DC; Cullinan GJ; Bendele R; Kauffman RF; Bensch WR
    J Clin Invest; 1994 Jan; 93(1):63-9. PubMed ID: 8282823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships of selective estrogen receptor modulators: modifications to the 2-arylbenzothiophene core of raloxifene.
    Grese TA; Cho S; Finley DR; Godfrey AG; Jones CD; Lugar CW; Martin MJ; Matsumoto K; Pennington LD; Winter MA; Adrian MD; Cole HW; Magee DE; Phillips DL; Rowley ER; Short LL; Glasebrook AL; Bryant HU
    J Med Chem; 1997 Jan; 40(2):146-67. PubMed ID: 9003514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LY353381.HCl: a novel raloxifene analog with improved SERM potency and efficacy in vivo.
    Sato M; Turner CH; Wang T; Adrian MD; Rowley E; Bryant HU
    J Pharmacol Exp Ther; 1998 Oct; 287(1):1-7. PubMed ID: 9765314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time-dependent changes in biochemical bone markers and serum cholesterol in ovariectomized rats: effects of raloxifene HCl, tamoxifen, estrogen, and alendronate.
    Frolik CA; Bryant HU; Black EC; Magee DE; Chandrasekhar S
    Bone; 1996 Jun; 18(6):621-7. PubMed ID: 8806005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raloxifene, tamoxifen, nafoxidine, or estrogen effects on reproductive and nonreproductive tissues in ovariectomized rats.
    Sato M; Rippy MK; Bryant HU
    FASEB J; 1996 Jun; 10(8):905-12. PubMed ID: 8666168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and pharmacology of conformationally restricted raloxifene analogues: highly potent selective estrogen receptor modulators.
    Grese TA; Pennington LD; Sluka JP; Adrian MD; Cole HW; Fuson TR; Magee DE; Phillips DL; Rowley ER; Shetler PK; Short LL; Venugopalan M; Yang NN; Sato M; Glasebrook AL; Bryant HU
    J Med Chem; 1998 Apr; 41(8):1272-83. PubMed ID: 9548817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An estrogen receptor basis for raloxifene action in bone.
    Bryant HU; Glasebrook AL; Yang NN; Sato M
    J Steroid Biochem Mol Biol; 1999; 69(1-6):37-44. PubMed ID: 10418979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of SP500263, a novel selective estrogen receptor modulator, on bone, uterus, and serum cholesterol in the ovariectomized rat.
    Sutherland MK; Brady H; Gayo-Fung LM; Leisten J; Lipps SG; McKie JA; O'Leary E; Patnaik N; Anderson DW; Bhagwat SS; Stein B
    Calcif Tissue Int; 2003 Jun; 72(6):710-6. PubMed ID: 14563000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raloxifene inhibits bone turnover and prevents further cancellous bone loss in adult ovariectomized rats with established osteopenia.
    Evans GL; Bryant HU; Magee DE; Turner RT
    Endocrinology; 1996 Oct; 137(10):4139-44. PubMed ID: 8828469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypocholesterolemic activity of raloxifene (LY139481): pharmacological characterization as a selective estrogen receptor modulator.
    Kauffman RF; Bensch WR; Roudebush RE; Cole HW; Bean JS; Phillips DL; Monroe A; Cullinan GJ; Glasebrook AL; Bryant HU
    J Pharmacol Exp Ther; 1997 Jan; 280(1):146-53. PubMed ID: 8996192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of raloxifene on tibia histomorphometry in ovariectomized rats.
    Evans G; Bryant HU; Magee D; Sato M; Turner RT
    Endocrinology; 1994 May; 134(5):2283-8. PubMed ID: 8156931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological actions of a novel, potent, tissue-selective benzopyran estrogen.
    Galbiati E; Caruso PL; Amari G; Armani E; Ghirardi S; Delcanale M; Civelli M
    J Pharmacol Exp Ther; 2002 Oct; 303(1):196-203. PubMed ID: 12235251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective estrogen receptor modulators: an alternative to hormone replacement therapy.
    Bryant HU; Dere WH
    Proc Soc Exp Biol Med; 1998 Jan; 217(1):45-52. PubMed ID: 9421206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.